MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Corcept Therapeutics Incorporated DIO Ratio 2011-2026 | CORT
Annual DIO Ratio Corcept Therapeutics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 356 | 338 | 389 | 376 | 342 | 338 | 360 | 331 | 470 | 413 | 451 | 499 | 2.8 K | 3.42 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.42 K | 331 | 777 |
Quarterly DIO Ratio Corcept Therapeutics Incorporated
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 399 | 244 | 354 | 426 | 261 | 281 | 265 | 400 | 386 | 211 | - | 206 | 176 | 367 | - | 346 | 317 | 355 | - | 368 | 363 | 251 | - | 341 | 359 | 374 | - | 330 | 374 | 362 | - | 428 | 539 | - | - | - | - | - | - | 600 | 350 | 436 | - | 469 | 512 | 604 | - | 2.5 K | 4.35 K | 4.45 K | - | 3.24 K | 1.62 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.45 K | 176 | 742 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |  Britain |
 |
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
150 | $ 34.45 | 4.74 % | $ 927 M | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | Britain |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Grifols, S.A.
GRFS
|
0.000171 | $ 8.19 | 4.46 % | $ 5.57 B |  Spain |
 |
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.62 | -0.61 % | $ 431 M | Britain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
185 | - | -4.36 % | $ 27 M | USA |
 |
Anika Therapeutics
ANIK
|
159 | $ 15.14 | 2.16 % | $ 217 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
78.4 | $ 97.08 | 1.55 % | $ 19 B | USA |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.51 | 2.03 % | $ 177 M | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 20.47 | 4.97 % | $ 2.6 B | USA |